Paroxetine Tablet, Film Coated
Product Images NDC 0904-5676

6 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 0904-5676). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of paroxetine hydrochloride, the active ingredient in PAROXETINE tablets. The diagram shows the molecular arrangement including a fluorophenyl group, a piperidine ring, and a methylenedioxyphenyl group, along with the hydrochloride component.*
FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
A forest plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of paroxetine hydrochloride when administered with interacting drugs Pimozide, Desipramine, Propranolol, Digoxin, and Phenytoin. The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10.*
FDA Label Image

Figure2.jpg (Figure2)

Figure2.jpg (Figure2)
A forest plot showing the fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) for paroxetine when administered with various interacting drugs including cimetidine, phenobarbital, phenytoin, digoxin, and diazepam. The x-axis represents the change relative to a reference value from 0 to 2.*
FDA Label Image

Figure3.jpg (Figure3)

Figure3.jpg (Figure3)
A pharmacokinetic chart showing fold change and 90% confidence intervals for paroxetine hydrochloride in populations with varying degrees of renal and hepatic impairment, age groups over 65 years at different doses, and by gender (males). The x-axis shows change relative to a reference value, illustrating Cmax, Cmin, and AUC parameters for each group.*
FDA Label Image

10mg Carton Label (Image 01)

10mg Carton Label (Image 01)
The image shows a unit dose label for Paroxetine 10 mg tablets, USP, from Major Pharmaceuticals. It includes the NDC 0904-5676-61 and states the package contains 100 tablets (10 x 10). Directions for pharmacists to dispense with a medication guide are noted, along with storage instructions and safety warnings. The label also mentions the product is Rx only and intended for institutional use.*
FDA Label Image

20mg Carton Label (Image 02)

20mg Carton Label (Image 02)
Paroxetine 20 mg tablets, USP, film-coated oral tablets by Major Pharmaceuticals. The unit dose packaging contains 100 tablets (10 x 10) and is labeled for Rx only. The label includes directions to dispense with a medication guide and storage instructions. Bar code and distributor information (Major Pharmaceuticals, Indianapolis, IN) are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.